ProCE Banner Activity

Emerging Insights on Adverse Events During ART and Implications for Treatment: Nephrotoxicity and Long-Acting Injectables

Podcast Episodes
Hear insights and answers to audience questions from Fidelia Bernice, PharmD, and Aadia I. Rana, MD, on HIV ART safety and tolerability including recent data on nephrotoxicity and safety with long-acting injectables.

Released: November 16, 2021

Expiration: November 15, 2022

Share

Faculty

Fidelia Bernice

Fidelia Bernice, PharmD

Clinical Pharmacy Specialist, Infectious Diseases
Department of Pharmacy
University of Maryland Medical Center
Baltimore, Maryland

Aadia I. Rana

Aadia I. Rana, MD

Professor of Medicine
Division of Infectious Diseases
University of Alabama at Birmingham Heersink School of Medicine
Birmingham, Alabama

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Educational grant provided by

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare

Faculty Disclosure

Primary Author

Fidelia Bernice, PharmD

Clinical Pharmacy Specialist, Infectious Diseases
Department of Pharmacy
University of Maryland Medical Center
Baltimore, Maryland

Fidelia Bernice, PharmD, has no relevant conflicts of interest to report.

Aadia I. Rana, MD

Professor of Medicine
Division of Infectious Diseases
University of Alabama at Birmingham Heersink School of Medicine
Birmingham, Alabama

Aadia I. Rana, MD, has disclosed that she has received funds for research support from Merck.